Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Review Status	Status Date	View
JYSZ2200058	注射用曲妥珠单抗	trastuzumab	Lyophilized	Biological Products	License Renew	2022-11-01				view
JYSB0500021	注射用曲妥珠单抗	trastuzumab	Lyophilized	Biological Products	Supplementary Application	2005-05-12		Certificate Issued	2005-09-23	view
CYSB2400136	注射用曲妥珠单抗	trastuzumab	Lyophilized	Biological Products(3.3)	Supplementary Application	2024-05-25	Anhui Anke Biotechnology (Group) Co Ltd			view
CYSB2101216	注射用曲妥珠单抗	trastuzumab	Lyophilized	Biological Products	Supplementary Application	2021-10-09	Shanghai Henlius Biopharmaceutical Co Ltd			view
JYSB2300117	注射用曲妥珠单抗	trastuzumab	Lyophilized	Biological Products	Supplementary Application	2023-07-12				view
CXSS2101019	注射用曲妥珠单抗	trastuzumab	Lyophilized	Biological Products(3.3)	New Drug Application	2021-08-05	Anhui Anke Biotechnology (Group) Co Ltd			view
CYSB2400292	注射用曲妥珠单抗	trastuzumab	Lyophilized	Biological Products(3.3)	Supplementary Application	2024-11-09	Anhui Anke Biotechnology (Group) Co Ltd			view
JXSL0500008	注射用曲妥珠单抗	trastuzumab	Lyophilized	Biological Products(1)	Import Drug Application	2005-04-01	Roche Pharma (Schweiz) Ltd	Certificate Issued	2005-11-16	view
CXSS2200005	注射用曲妥珠单抗	trastuzumab	Lyophilized	Biological Products(3.3)	New Drug Application	2022-01-14	Hisun Biopharmaceutical Co Ltd			view
JYSB2300118	注射用曲妥珠单抗	trastuzumab	Lyophilized	Biological Products	Supplementary Application	2023-07-12				view
JYSB2101009	注射用曲妥珠单抗	trastuzumab	Lyophilized	Biological Products(3.1)	Supplementary Application	2021-04-12				view
CYSB2400281	注射用曲妥珠单抗	trastuzumab	Lyophilized	Biological Products(3.3)	Supplementary Application	2024-10-25	QILU Pharmaceutical Co Ltd			view
CYSB2101224	注射用曲妥珠单抗	trastuzumab	Lyophilized	Biological Products(原2)	Supplementary Application	2021-10-14				view
JYSZ2200057	注射用曲妥珠单抗	trastuzumab	Lyophilized	Biological Products	License Renew	2022-11-01				view
CXSS2300027	注射用曲妥珠单抗	trastuzumab	Lyophilized	Biological Products(3.3)	New Drug Application	2023-04-27	QILU Pharmaceutical Co Ltd			view
JXSL1300042	注射用曲妥珠单抗	trastuzumab	Lyophilized	Biological Products	Import Drug Application	2013-07-08	Pfizer Inc	Certificate Issued	2015-10-15	view
CYSB2101225	注射用曲妥珠单抗	trastuzumab	Lyophilized	Biological Products(原2)	Supplementary Application	2021-10-14				view
CYSB2400265	注射用曲妥珠单抗	trastuzumab	Lyophilized	Biological Products(3.3)	Supplementary Application	2024-10-09	QILU Pharmaceutical Co Ltd			view
CYSB2101215	注射用曲妥珠单抗	trastuzumab	Lyophilized	Biological Products	Supplementary Application	2021-10-09	Shanghai Henlius Biopharmaceutical Co Ltd			view
JXSL0500007	注射用曲妥珠单抗	trastuzumab	Lyophilized	Biological Products(1)	Import Drug Application	2005-04-01	Roche Pharma (Schweiz) Ltd	Certificate Issued	2005-11-16	view